Quoin Pharmaceuticals (QNRX) News Today $0.63 +0.00 (+0.70%) (As of 02:43 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period QNRX: International Sites Participating in QRX003 NS Study, Studying QRX003 for Additional Diseases, in Younger PopulationsNovember 12, 2024 | msn.comPromising Developments and Financial Stability Propel Quoin Pharmaceuticals’ Buy RatingNovember 9, 2024 | markets.businessinsider.comQuoin Pharmaceuticals continues to evaluate M&A opportunitiesNovember 8, 2024 | markets.businessinsider.comQuoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2024 Financial ResultsNovember 8, 2024 | markets.businessinsider.comQuoin initiates clinical testing of QRX003 in pediatric NS trialNovember 6, 2024 | markets.businessinsider.comQuoin Pharmaceuticals to Announce Third Quarter 2024 Financial Results on Thursday, November 7, 2024October 31, 2024 | globenewswire.comQuoin Pharmaceuticals expands UK clinical trials for rare diseaseOctober 25, 2024 | investing.comQuoin Pharmaceuticals announces further expansion of on-going NS studiesOctober 23, 2024 | markets.businessinsider.comQuoin Pharmaceuticals Announces Further International Expansion of Ongoing Clinical Trials for Netherton SyndromeOctober 22, 2024 | markets.businessinsider.comQuoin Pharmaceuticals (NASDAQ:QNRX) Stock Quotes, Forecast and News SummaryOctober 17, 2024 | benzinga.comQuoin Pharmaceuticals Announces Insider Share Purchases by Co-Founders CEO and COOSeptember 9, 2024 | globenewswire.comDenise P. Carter Buys 31,813 Shares of Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) StockSeptember 6, 2024 | insidertrades.comQNRX: Assessing QRX003 For Multiple Conditions; Opening International Netherton Syndrome Clinical SitesAugust 22, 2024 | finance.yahoo.comQNRX Stock Earnings: Quoin Pharmaceuticals Beats EPS for Q2 2024August 9, 2024 | msn.comQuoin Pharmaceuticals, Inc.: Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2024 Financial ResultsAugust 8, 2024 | finanznachrichten.deQuoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2024 Financial ResultsAugust 8, 2024 | globenewswire.comQuoin Pharmaceuticals to Initiate Clinical Study for Peeling Skin SyndromeAugust 6, 2024 | globenewswire.comQuoin Pharmaceuticals to Announce Second Quarter 2024 Financial Results on Thursday, August 8, 2024August 1, 2024 | globenewswire.comQuoin Pharmaceuticals to Sponsor the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 National ConferenceJune 25, 2024 | globenewswire.comQuoin Pharmaceuticals Announces Signing of Research Agreement with University College Cork (UCC), IrelandJune 12, 2024 | globenewswire.comQNRX: Protocol Modifications Potentially Accelerate, Expand QRX003 ApprovalsMay 22, 2024 | finance.yahoo.comQuoin Pharmaceuticals Non-GAAP EPS of -$1.11 misses by $0.70May 9, 2024 | msn.comQuoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial ResultsMay 9, 2024 | finance.yahoo.comQuoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial ResultsMay 9, 2024 | globenewswire.comQuoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024May 2, 2024 | globenewswire.comQuoin Pharmaceuticals, Ltd. (QNRX) Q4 2023 Earnings Call TranscriptMarch 16, 2024 | seekingalpha.comMaxim Group Maintains Buy Rating for Quoin Pharmaceuticals: Here's What You Need To KnowMarch 15, 2024 | markets.businessinsider.comQuoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | finance.yahoo.comQuoin Pharmaceuticals, Inc.: Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial ResultsMarch 14, 2024 | finanznachrichten.deQuoin Pharmaceuticals: Q4 Earnings InsightsMarch 14, 2024 | benzinga.comQuoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial ResultsMarch 13, 2024 | globenewswire.comWhy Quoin Pharmaceuticals (QNRX) Shares Are NosedivingMarch 7, 2024 | msn.comQuoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ETMarch 7, 2024 | globenewswire.comQNRX: Potential Pool of Study Participants Expands; Financial Position StrengthsMarch 6, 2024 | finance.yahoo.comQTI, RNLX and MTC among pre-market losersMarch 5, 2024 | seekingalpha.comWhy Is Quoin Pharmaceuticals (QNRX) Stock Down 50% Today?March 5, 2024 | msn.comQuoin Pharmaceuticals Announces Pricing of $6.5 Million Public OfferingMarch 5, 2024 | finance.yahoo.comQuoin Pharma Shares Double After FDA Grants Clearance for Teens in QRX003 TrialMarch 4, 2024 | marketwatch.comQuoin Pharma Says FDA Clears Recruitment Of Teen Subjects For Two Ongoing Clinical Trials For QRX003March 4, 2024 | markets.businessinsider.comWhy Quoin Pharmaceutical Stock Is SoaringMarch 4, 2024 | msn.comBuy Rating for Quoin Pharmaceuticals Amid Promising Netherton Syndrome Drug ProspectsDecember 15, 2023 | markets.businessinsider.comQuoin Pharmaceuticals Ltd ADRDecember 13, 2023 | morningstar.comQuoin Pharmaceuticals, Inc.: Quoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton SyndromeDecember 13, 2023 | finanznachrichten.deFDA Clears Quoin Pharma's Protocol Amendments For QRX003 Trials In Netherton Syndrome TreatmentDecember 13, 2023 | markets.businessinsider.comQNRX: Planned Protocol Modifications Might Accelerate QRX003 Regulatory ApprovalNovember 13, 2023 | finance.yahoo.comQuoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Q3 2023 Earnings Call TranscriptNovember 10, 2023 | finance.yahoo.comQuoin Pharmaceuticals Ltd ADR QNRXNovember 10, 2023 | morningstar.comQuoin Pharmaceuticals GAAP EPS of -$7.61 misses by $4.89November 9, 2023 | msn.comQuoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2023 Financial ResultsNovember 8, 2023 | finance.yahoo.comPreview: Quoin Pharmaceuticals's EarningsNovember 7, 2023 | benzinga.com Get Quoin Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for QNRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW QNRX Media Mentions By Week QNRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. QNRX News Sentiment▼-1.000.47▲Average Medical News Sentiment QNRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. QNRX Articles This Week▼20▲QNRX Articles Average Week Get Quoin Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for QNRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LYRA News Today QTI News Today PAVM News Today PETV News Today LUCY News Today ICU News Today STRR News Today TTOO News Today PXDT News Today NURO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:QNRX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quoin Pharmaceuticals, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quoin Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free QNRX Stock Alerts